Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone.

Winans SA, Luce AM, Hasbun R.

Infection. 2013 Aug;41(4):769-74. doi: 10.1007/s15010-013-0477-0. Epub 2013 May 19.

PMID:
23686435
[PubMed - indexed for MEDLINE]
2.

A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus.

Wieland BW, Marcantoni JR, Bommarito KM, Warren DK, Marschall J.

Clin Infect Dis. 2012 Mar 1;54(5):585-90. doi: 10.1093/cid/cir857. Epub 2011 Dec 5.

PMID:
22144536
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.

BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279.

PMID:
22011388
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.

Wynn M, Dalovisio JR, Tice AD, Jiang X.

South Med J. 2005 Jun;98(6):590-5.

PMID:
16004164
[PubMed - indexed for MEDLINE]
5.

Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.

Tice AD, Hoaglund PA, Shoultz DA.

Am J Med. 2003 Jun 15;114(9):723-8.

PMID:
12829198
[PubMed - indexed for MEDLINE]
6.

Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.

Zeller V, Durand F, Kitzis MD, Lhotellier L, Ziza JM, Mamoudy P, Desplaces N.

Antimicrob Agents Chemother. 2009 Mar;53(3):883-7. doi: 10.1128/AAC.00389-08. Epub 2008 Dec 15.

PMID:
19075069
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.

Barr DA, Semple L, Seaton RA.

Int J Antimicrob Agents. 2012 May;39(5):407-13. doi: 10.1016/j.ijantimicag.2012.01.016. Epub 2012 Mar 23.

PMID:
22445493
[PubMed - indexed for MEDLINE]
8.

The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage.

Wu CK, Wang JH, Lee CH, Wu KL, Tai WC, Lu SN, Hu TH, Chuah SK.

PLoS One. 2013 Apr 22;8(4):e61666. doi: 10.1371/journal.pone.0061666. Print 2013.

PMID:
23630607
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital.

Madigan T, Banerjee R.

Pediatr Infect Dis J. 2013 Apr;32(4):346-9. doi: 10.1097/INF.0b013e31827ee1c2.

PMID:
23249915
[PubMed - indexed for MEDLINE]
10.

Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?

Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB, Oh MD.

Antimicrob Agents Chemother. 2011 Nov;55(11):5122-6. doi: 10.1128/AAC.00485-11. Epub 2011 Aug 8.

PMID:
21825299
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Outcomes of cefazolin versus ceftriaxone therapy in treating lower respiratory tract infections in adults.

Thompson D, Huse DM, Oster G.

Ann Pharmacother. 1992 Dec;26(12):1503-7.

PMID:
1482802
[PubMed - indexed for MEDLINE]
12.

Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.

Partridge DG, O'Brien E, Chapman AL.

Postgrad Med J. 2012 Jul;88(1041):377-81. doi: 10.1136/postgradmedj-2011-130355. Epub 2012 Feb 25.

PMID:
22366395
[PubMed - indexed for MEDLINE]
13.

Does empiric antibiotic therapy change MRSA [corrected] hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital.

Janis JE, Hatef DA, Reece EM, Wong C.

Plast Reconstr Surg. 2014 Apr;133(4):511e-8e. doi: 10.1097/PRS.0000000000000018. Erratum in: Plast Reconstr Surg. 2014 Sep;134(3):580.

PMID:
24675203
[PubMed - indexed for MEDLINE]
14.

Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.

Youngster I, Shenoy ES, Hooper DC, Nelson SB.

Clin Infect Dis. 2014 Aug;59(3):369-75. doi: 10.1093/cid/ciu301. Epub 2014 Apr 29.

PMID:
24785233
[PubMed - in process]
15.

Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.

Kopp BJ, Nix DE, Armstrong EP.

Ann Pharmacother. 2004 Sep;38(9):1377-82. Epub 2004 Jul 20.

PMID:
15266044
[PubMed - indexed for MEDLINE]
16.

Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility.

Capitano B, Leshem OA, Nightingale CH, Nicolau DP.

J Am Geriatr Soc. 2003 Jan;51(1):10-6.

PMID:
12534839
[PubMed - indexed for MEDLINE]
17.

Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. A randomized, double-blind trial.

Sanchez-Ramos L, McAlpine KJ, Adair CD, Kaunitz AM, Delke I, Briones DK.

Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):129-33.

PMID:
7847521
[PubMed - indexed for MEDLINE]
18.

Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.

Kini AR, Shetty V, Kumar AM, Shetty SM, Shetty A.

J Pediatr Orthop B. 2013 Mar;22(2):158-66. doi: 10.1097/BPB.0b013e32835c530a.

PMID:
23249998
[PubMed - indexed for MEDLINE]
19.

Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.

Seaton RA, Bell E, Gourlay Y, Semple L.

J Antimicrob Chemother. 2005 May;55(5):764-7. Epub 2005 Mar 16.

PMID:
15772137
[PubMed - indexed for MEDLINE]
Free Article
20.

Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr.

Clin Infect Dis. 2007 Jan 15;44(2):190-6. Epub 2006 Dec 8.

PMID:
17173215
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk